Bio-behavioral Research At The Intersection of Cancer and Aging
癌症与衰老交叉点的生物行为研究
基本信息
- 批准号:8952028
- 负责人:
- 金额:$ 92.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAffectAgeAgingAging-Related ProcessAwardBasic ScienceBehavioralBehavioral ResearchBiological AgingCancer BurdenCancer SurvivorCaringClinicalCognitiveCollaborationsCommunicationDataEarly DiagnosisEmotionalEnsureFundingFutureGoalsGrowthHeterogeneityIndividualIntervention TrialLaboratoriesLeftLifeLongevityMalignant NeoplasmsModelingOlder PopulationOutcomePoliciesPopulationPopulation SciencesProductivityRecording of previous eventsResearchResearch InfrastructureResearch PersonnelRiskRoleSeriesSurvivorsSystemic TherapyTestingTraining SupportTreatment outcomeagedaging populationcancer carecohortdesignexperiencefrailtyfunctional declinefunctional outcomeshigh rewardhigh riskinnovationinterestlifestyle factorslifestyle interventionmalignant breast neoplasmnovelpublic health relevancerandomized trialresearch studysurvivorshiptreatment effect
项目摘要
DESCRIPTION (provided by applicant): We are experiencing unprecedented growth in the numbers of individuals at risk for, or living with cancer due to population aging, greater use of early detection, advances in treatment, and increasing lifespan. By 2030, nearly 50% of the 45 million new cases and 75% of the 20 million cancer survivors will be aged 60 or older ("older"). Most of these older survivors are interested in and will benefit from systemic therapies. However, these treatments often have adverse effects on function, although data are largely from studies with younger survivors. Since only 4% of NCI-funded survivorship research specifically examines outcomes among older survivors, we know little about how the substantial heterogeneity in aging processes ("biological age") affects risk for adverse functional outcomes among those of comparable chronological age. These data are important because they could affect treatment decisions, survivorship care planning, and ability to live independently. This Outstanding Investigator Award will use a bio-behavioral framework to conduct population sciences research at the intersection of cancer and aging to fill these gaps. Data, infrastructure,
and established collaborations from an extant NCI-funded older cohort will be leveraged to iteratively build new studies to test novel hypotheses. Such cohorts are the population science equivalent of a basic science laboratory used for a series of experiments. The goals of the high-risk/high-reward studies are to: physical, emotional, social and role function; 1) define long-term
trajectories of decline in cognitive, determine bio-behavioral risks for decline; and examine how systemic therapy and lifestyle factors moderate these relationships; 2) conduct exploratory research on biological age markers to determine feasibility and clinical utility for predicting ris and trajectory of functional decline; 3) conduct pilot randomized trials of the impact of lifestyle
interventions on biological age markers and functional outcomes; and 4) enhance long-term clinical and policy impact by incorporating data into policy modeling, engaging survivors in design and communication of results, and supporting training. This research is innovative in use of a bio-behavioral framework and inclusion of policy modeling. The findings will move the field forward by shifting the paradigms of research and care for the growing older population; determining whether biological age markers can identify survivors at greatest risk for functional declines; informing future intervention trials; and expanding the limited number of cancer and aging researchers. The PIs history of productivity and strong institutional and collaborative support will ensure that the research will have the intended impact. Overall, the unique population science perspectives of these studies will add important diversity to the multi-disciplinary approaches needed for reducing the burden of cancer in older survivors.
描述(由申请人提供):由于人口老龄化,早期检测的更多使用,治疗的进步和寿命的延长,我们正在经历癌症风险或癌症患者数量的前所未有的增长。到2030年,4500万新发病例中的近50%和2000万癌症幸存者中的75%将年龄在60岁或以上(“老年人”)。这些老年幸存者中的大多数对系统治疗感兴趣并将从中受益。然而,这些治疗往往对功能产生不利影响,尽管数据主要来自对年轻幸存者的研究。由于只有4%的国家癌症研究所资助的生存研究专门研究老年幸存者的结果,我们知道很少的老化过程中的实质性异质性(“生物年龄”)如何影响不良功能结果的风险之间的可比实足年龄。这些数据很重要,因为它们可能影响治疗决策,生存护理计划和独立生活的能力。该杰出研究者奖将使用生物行为框架在癌症和衰老的交叉点进行人口科学研究,以填补这些空白。数据,基础设施,
和现有的国家癌症研究所资助的老年队列建立的合作将被用来迭代建立新的研究,以测试新的假设。这些群体在人口科学中相当于一个基础科学实验室,用于进行一系列实验。高风险/高回报研究的目标是:身体、情感、社会和角色功能; 1)定义长期的
认知能力下降的轨迹,确定下降的生物行为风险;并检查系统治疗和生活方式因素如何调节这些关系; 2)对生物年龄标记进行探索性研究,以确定预测RIS和功能下降轨迹的可行性和临床效用; 3)对生活方式的影响进行试点随机试验
对生物年龄标志物和功能结果的干预;以及4)通过将数据纳入政策建模,让幸存者参与设计和结果交流以及支持培训,增强长期临床和政策影响。本研究在使用生物行为框架和纳入政策建模方面具有创新性。这些发现将通过改变研究和护理日益增长的老年人口的范式来推动该领域的发展;确定生物年龄标志物是否可以识别功能下降风险最大的幸存者;为未来的干预试验提供信息;以及扩大癌症和衰老研究人员的有限数量。PI的生产力历史和强大的机构和协作支持将确保研究产生预期的影响。总体而言,这些研究独特的人口科学视角将为减少老年幸存者癌症负担所需的多学科方法增加重要的多样性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeanne Mandelblatt其他文献
Jeanne Mandelblatt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeanne Mandelblatt', 18)}}的其他基金
Social Determinants of Health as Transducers of Cellular Aging: A New Multi-level Paradigm to Reduce Survivorship Disparities at the Intersection of Cancer and Aging
健康的社会决定因素作为细胞衰老的传导者:减少癌症和衰老交叉点的生存差异的新的多层次范式
- 批准号:
10736380 - 财政年份:2023
- 资助金额:
$ 92.93万 - 项目类别:
A Simulation Modeling Study to Support Personalized Breast Cancer Prevention and Early Detection in High-Risk Women
支持高危女性个性化乳腺癌预防和早期检测的模拟模型研究
- 批准号:
10371141 - 财政年份:2021
- 资助金额:
$ 92.93万 - 项目类别:
Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive Decline
认知衰老、阿尔茨海默病和癌症相关的认知能力下降
- 批准号:
10715609 - 财政年份:2020
- 资助金额:
$ 92.93万 - 项目类别:
Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive Decline
认知衰老、阿尔茨海默病和癌症相关的认知能力下降
- 批准号:
10617392 - 财政年份:2020
- 资助金额:
$ 92.93万 - 项目类别:
Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive Decline
认知衰老、阿尔茨海默病和癌症相关的认知能力下降
- 批准号:
10408070 - 财政年份:2020
- 资助金额:
$ 92.93万 - 项目类别:
Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive Decline
认知衰老、阿尔茨海默病和癌症相关的认知能力下降
- 批准号:
10225649 - 财政年份:2020
- 资助金额:
$ 92.93万 - 项目类别:
Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive Decline
认知衰老、阿尔茨海默病和癌症相关的认知能力下降
- 批准号:
10028895 - 财政年份:2020
- 资助金额:
$ 92.93万 - 项目类别:
Bio-behavioral Research At The Intersection of Cancer and Aging
癌症与衰老交叉点的生物行为研究
- 批准号:
9978577 - 财政年份:2015
- 资助金额:
$ 92.93万 - 项目类别:
Bio-behavioral Research At The Intersection of Cancer and Aging
癌症与衰老交叉点的生物行为研究
- 批准号:
10224107 - 财政年份:2015
- 资助金额:
$ 92.93万 - 项目类别:
Bio-behavioral Research At The Intersection of Cancer and Aging
癌症与衰老交叉点的生物行为研究
- 批准号:
9117500 - 财政年份:2015
- 资助金额:
$ 92.93万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 92.93万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 92.93万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 92.93万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 92.93万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 92.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 92.93万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 92.93万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 92.93万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 92.93万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 92.93万 - 项目类别:
Miscellaneous Programs